Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease

Joint Authors

Schoenberger, Scott D.
Kim, Stephen J.

Source

International Journal of Inflammation

Issue

Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-8, 8 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2013-01-14

Country of Publication

Egypt

No. of Pages

8

Main Subjects

Diseases
Medicine

Abstract EN

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used extensively in ophthalmology for pain and photophobia after photorefractive surgery and to reduce miosis, inflammation, and cystoid macular edema following cataract surgery.

In recent years, the US Food and Drug Administration has approved new topical NSAIDs and previously approved NSAIDs have been reformulated.

These changes may allow for greater drug penetration into the retina and thereby offer additional therapeutic advantages.

For example, therapeutic effects on diabetic retinopathy and age-related macular degeneration may now be achievable.

We provide an updated review on the scientific rationale and clinical use of NSAIDs for retinal disease.

American Psychological Association (APA)

Schoenberger, Scott D.& Kim, Stephen J.. 2013. Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation،Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-460067

Modern Language Association (MLA)

Schoenberger, Scott D.& Kim, Stephen J.. Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation No. 2013 (2013), pp.1-8.
https://search.emarefa.net/detail/BIM-460067

American Medical Association (AMA)

Schoenberger, Scott D.& Kim, Stephen J.. Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation. 2013. Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-460067

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-460067